ESPR Esperion Therapeutics, Inc.
3.180USD0.00%Mkt Cap: 819.46M $P/E: Infinity85d ago
Industry Peers
Drug Manufacturers - Specialty & Generic$64.30BUSDP/E 25.0
$56.90BUSD
$46.26BUSDP/E 66.1
$38.79BUSDP/E 18.0
$29.51BUSDP/E 11.7
$28.27BUSDP/E 12.1
$23.01BUSDP/E 19.2
$20.24BUSD
$14.14BUSDP/E 110.6
$14.66BUSDP/E 21.1
$12.60BUSDP/E 22.8
$11.25BUSD
$10.26BUSDP/E 28.0
$8.59BUSDP/E 19.2
$7.17BUSDP/E 112.5
$7.09BUSDP/E 41.5
$6.92BUSD
$6.54BUSDP/E 24.3
$5.87BUSDP/E 77.1
APTX
Apotex Health Corp.$5.17BUSD
Key Statistics
Company
Market Cap819.46M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)—
Revenue/Share—
Last Price3.180 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS29664W1053
Valuation
P/E (Trailing)Infinity
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)—
EPS (Forward)—
52W Range
1.10068% of range4.180
52W High4.180 USD
52W Low1.100 USD
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin—
ROE—
ROA—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate—
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg—
Avg Vol (30d)12.06M
Avg Vol (10d)—
Technical Indicators
RSI (14)65.0
MACD0.0308
MACD Signal0.0382
MACD Hist.-0.0074
BB Upper3.187 USD
BB Middle3.162 USD
BB Lower3.137 USD
BB Width1.57%
ATR (14)0.0210 USD
Vol Ratio (20d)0.00x